Skip to main content

Table 2 Comparison of the treatment and prognosis among choriocarcinoma arising from mole vs from biparental pregnancy vs non-gestational Choriocarcinoma

From: Using short tandem repeat analysis for choriocarcinoma diagnosis: a case series

  

choriocarcinoma arising from mole (n = 9)

Choriocarcinoma from biparental pregnancy (n = 5)

non-gestational choriocarcinoma (n = 1)

Surgery (n, %)

Hysterectomy

2 (22%)

2 (40%)

0

Uterine curetting

5 (56%)

2 (40%)

0

Pelvic mass resection

1 (11%)

0

1 (100%)

Adnexectomy

1 (11%)

1 (420%)

1 (100%)

Prognosis(n)

Alive, no evidence of disease

9

5

 

Lost of follow-up

  

1

Chemotherapy (n, %)

First-line single-agent alone

3 (33.3%)

0

0

First-line multi-agent alone

4 (44.4%)

2 (40%)

1 (100%)

Salvage multi-agent chemotherapy

2 (22.2%)

3 (60%)

0